Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Vanderbilt University Medical Center
With
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Pseudohypoparathyroidism type 1a (PHP1a) is a genetic disorder that causes early-onset, syndromic obesity and cognitive impairment. This study aims to evaluate eating behaviors, cognition and executive function in children with PHP1a, compared with healthy siblings and matched obese controls.
Age
6–18
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
Clinical diagnosis of PHP1a, sibling of a patient with PHP1a or matched obese control
You may not be if
Treatment with appetite-altering drug or initiation of a new weight loss program in the past 3 months
Type 2 diabetes
Obesity due to a genetic syndrome, growth hormone deficiency, untreated hypothyroidism, Cushing syndrome or exogenous glucocorticoid administration
Weight loss greater than 10% over the previous 6 months
Autism or other significant learning disorder
Type 2 diabetes
Other significant medical condition
Clareo Health | Early-onset Obesity and Cognitive Impairment in Children With Pseudohypoparathyroidism
